The Latin American pharmaceutical industry has grown steadily, and shows many signs that it will continue in the same direction, with demand for medicines and proprietary drugs set to grow strongly across the region. The latest Canning Paper takes a closer look at this industry, analysing the data and drawing out some of its key issues in the region, namely controversy over pharmaceuticals pricing and attempts to attract pharma investment. The paper also zooms in on three countries, of particular interest in different ways: Brazil, Mexico and Cuba.
Seminar
Canning Paper Presentation: the Latin American Pharmaceutical Industry
- Canning House, 126 Wigmore Street, London
The Latin American pharmaceutical industry has grown steadily, and shows many signs that it will continue in the same direction, with demand for medicines and proprietary drugs set to grow strongly across the region. The latest Canning Paper takes a closer look at this industry, analysing the data and drawing out some of its key issues in the region, namely controversy over pharmaceuticals pricing and attempts to attract pharma investment. The paper also zooms in on three countries, of particular interest in different ways: Brazil, Mexico and Cuba.
Andrew Thompson, author of the paper, will present its broad findings. Miriam Palacios Callender, a Cuban-born pharmaceutical scientist, will focus on the biotechnology industry in Cuba and possible areas of collaboration with the UK. Chiara Cochetti, Key Account Manager at IQVIA, will speak about the industry from a business perspective. Professor Ken Shadlen from the LSE will chair the event. The presentations will be followed by an opportunity for Q&A.
Share This Event
Share this event on social media using the buttons below.